| Franklin Templeton International Services S.à r.l. | RV Sector Biotecnología | 40,89% | 3,98% | | | |
| Pictet Asset Management (Europe) SA | RV Sector Biotecnología | 35,92% | 3,92% | | | |
| Candriam | RV Sector Biotecnología | 29,65% | 6,49% | | | |
| Polar Capital LLP | RV Sector Biotecnología | 25,38% | 14,03% | | | |
| Janus Henderson Investors | RV Sector Biotecnología | 25,15% | 15,43% | | | |
| Medical Strategy GmbH | RV Sector Biotecnología | 22,51% | 7,31% | | | |
| Welzia Management SGIIC | RV Sector Biotecnología | 21,59% | — | | | |
| Sectoral Asset Management Inc | RV Sector Biotecnología | 19,12% | 3,02% | | | |
| UBS Asset Management (Europe) S.A. | RV Sector Biotecnología | 18,94% | 3,73% | | | |
| Erste Asset Management GmbH | RV Sector Biotecnología | 14,76% | 4,55% | | | |
| JPMorgan Asset Management (Europe) S.à r.l. | RV Sector Biotecnología | 11,60% | -9,24% | | | |
| DNB Asset Management SA | RV Sector Biotecnología | 9,38% | — | | | |
| DWS Investment GmbH | RV Sector Biotecnología | 8,57% | 4,75% | | | |
| Abante Asesores Gestión SGIIC | RV Sector Biotecnología | 6,30% | -5,18% | | | |
| Andbank Wealth Management SGIIC | RV Sector Biotecnología | -1,41% | — | | | |
